Vizianagaram, India

Sreenivas Reddy

This inventor holds 1 USPTO granted patent. Top assignee: Shilpa Medicare Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sreenivas Reddy. Retrieved from https://idiyas.com/inventor/sreenivas-reddy-5myccfim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sreenivas Reddy: Innovator in Pharmaceutical Compositions

Introduction

Sreenivas Reddy is a notable inventor based in Vizianagaram, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions.

Latest Patents

Sreenivas Reddy holds a patent for a pharmaceutical composition comprising lenvatinib mesylate. This invention includes a stabilizer in an amount of about 10% to about 20% based on the total weight of the composition. The stabilizer is selected from the group consisting of calcium hydroxide and potassium hydroxide. This patent represents a crucial advancement in the formulation of lenvatinib, which is used in cancer treatment.

Career Highlights

Sreenivas Reddy is associated with Shilpa Medicare Limited, a prominent company in the pharmaceutical sector. His work at this organization has allowed him to focus on developing innovative solutions that address critical health challenges.

Collaborations

Some of his coworkers include Krishnamurthy Toppaladoddi and Nijaguni Revansiddayya Rudraswamy Math. Their collaboration has likely contributed to the success of various projects within the company.

Conclusion

Sreenivas Reddy's contributions to pharmaceutical innovations, particularly through his patent on lenvatinib compositions, highlight his role as a key inventor in the industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…